Atopic Dermatitis Highlights From AAD 2023 Atopic Dermatitis Highlights From AAD 2023

The safety of abrocitinib, data on IL-22 inhibition, and the link between atopic dermatitis (AD) and inflammatory bowel disease top the AD highlights from AAD 2023, as reported by Dr Joel Gelfand.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news